Nomic
Montréal
About Nomic
Nomic is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. They are building the nELISA, a next-generation protein profiling platform for measuring proteins at scale and at high throughput. They offer scientists protein profiling solutions and empower them to decide the scope and scale of their experiments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $60.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2024)
- Website: nomic.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Market Research, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/nomic-4856 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.